Home LiteratureArticle Details
PMID: 8879222 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.

The Journal of experimental medicine ·Vol. 184 ·No. 4 ·1996-10-01 ·Pages 1513-8

Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W

Abstract

Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L. Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains. The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.

MeSH Terms
Biological Specimen Banks Brain/pathology Cell Death Fas Ligand Protein Histocytochemistry/methods Humans Immunohistochemistry Membrane Glycoproteins/isolation & purification Multiple Sclerosis/etiology Neuroglia/chemistry,pathology Tissue Distribution Up-Regulation fas Receptor/isolation & purification
Chemicals
FASLG protein, human Fas Ligand Protein Membrane Glycoproteins fas Receptor
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Dowling P
Neurology Service, Department of Veterans Affairs Medical Center, East Orange, New Jersey 07018, USA.
Shang G
Raval S
Menonna J
Cook S
Husar W
References (29)
29 references, click to expand
  1. Fas ligand-induced apoptosis as a mechanism of immune privilege.
    Science. 1995 Nov 17;270(5239):1189-92 PMID: 7502042
  2. Immunologic mechanisms and therapy in multiple sclerosis.
    Immunol Rev. 1995 Apr;144:75-107 PMID: 7590822
  3. Fas antigen expression in brains of patients with Alzheimer-type dementia.
    Brain Res. 1995 Oct 16;695(2):137-45 PMID: 8556323
  4. Fas ligand in human serum.
    Nat Med. 1996 Mar;2(3):317-22 PMID: 8612231
  5. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
    Nature. 1996 Apr 25;380(6576):723-6 PMID: 8614469
  6. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.
    Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):574-8 PMID: 1370583
  7. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.
    J Immunol. 1992 Feb 15;148(4):1274-9 PMID: 1371136
  8. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
    Nature. 1992 Mar 26;356(6367):314-7 PMID: 1372394
  9. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
    J Cell Biol. 1992 Nov;119(3):493-501 PMID: 1400587
  10. A novel domain within the 55 kd TNF receptor signals cell death.
    Cell. 1993 Sep 10;74(5):845-53 PMID: 8397073
  11. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
    Lab Invest. 1993 Oct;69(4):415-29 PMID: 7693996
  12. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.
    Cell. 1993 Dec 17;75(6):1169-78 PMID: 7505205
  13. Pathogenesis of multiple sclerosis.
    Lancet. 1994 Jan 29;343(8892):271-5 PMID: 7905102
  14. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium.
    Int J Cancer. 1994 May 1;57(3):371-7 PMID: 8168998
  15. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.
    Blood. 1994 Aug 15;84(4):1201-8 PMID: 7519477
  16. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    J Clin Invest. 1994 Sep;94(3):954-64 PMID: 7521890
  17. Role of Fas ligand in apoptosis induced by hepatitis C virus infection.
    Biochem Biophys Res Commun. 1994 Oct 28;204(2):468-74 PMID: 7980502
  18. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
    Ann Neurol. 1995 Jan;37(1):82-8 PMID: 7818262
  19. Fas antigen mRNA induction in postischemic murine brain.
    Brain Res. 1994 Sep 19;657(1-2):342-6 PMID: 7529644
  20. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
    Nature. 1995 Feb 2;373(6513):438-41 PMID: 7530335
  21. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.
    Nature. 1995 Feb 2;373(6513):441-4 PMID: 7530336
  22. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.
    Nature. 1995 Feb 2;373(6513):444-8 PMID: 7530337
  23. The Fas death factor.
    Science. 1995 Mar 10;267(5203):1449-56 PMID: 7533326
  24. Expression of the Fas ligand in cells of T cell lineage.
    J Immunol. 1995 Apr 15;154(8):3806-13 PMID: 7706720
  25. Expression of the functional soluble form of human fas ligand in activated lymphocytes.
    EMBO J. 1995 Mar 15;14(6):1129-35 PMID: 7536672
  26. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Crit Rev Clin Lab Sci. 1995;32(2):121-82 PMID: 7598789
  27. A role for CD95 ligand in preventing graft rejection.
    Nature. 1995 Oct 19;377(6550):630-2 PMID: 7566174
  28. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
    J Exp Med. 1995 Nov 1;182(5):1223-30 PMID: 7595193
  29. Expression of Fas/APO-1 during the progression of astrocytomas.
    Cancer Res. 1995 Dec 1;55(23):5528-30 PMID: 7585627
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1996-10-01
Pages
1513-8
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192814
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com